Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotides optimized for kidney targeting

Antisense oligonucleotides optimized for kidney targeting

US Patent 8258105 · Granted Sep 4, 2012

Estimated economic value: $3,700,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for safely reducing thrombopoietin2025
Compounds and methods for treating oxalate-related diseases2025
GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof2024
Modulation of transthyretin expression2022
Modulation of transthyretin expression2022
Compounds and methods for treating oxalate-related diseases2022
Modulation of factor 11 expression2022
Modulation of factor 11 expression2022
Modulation of androgen receptor expression2021
Modulation of DYRK1B expression2020
Heterocyclic compounds and methods of use2019
Heterocyclic compounds and methods of use2019